Skip to main content
Year archive

Abliva — 2020 filings

All 43 regulatory filings released by Abliva (ABLI) in 2020, sourced directly from the official regulator.

43 Filings
2020 Period
2020 filings (43)
Filing Released Lang
Interim / Quarterly Report 2020
Interim / Quarterly Report 9M 2020
2020-11-20 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report 9M 2020
2020-11-20 English
Magnus Persson leaves the Board of Directors of Abliva AB to focus on role as founding partner at Eir Ventures
Board/Management Information
2020-10-08 English
Magnus Persson lämnar styrelsen för Abliva AB för att fokusera på sin roll som grundare och partner i Eir Ventures
Board/Management Information
2020-10-08 Swedish
Abliva intends to start a pivotal KL1333 study second half 2021
Earnings Release H2 2020
2020-09-09 English
Abliva avser att starta en pivotal klinisk studie med KL1333 under andra halvåret 2021
Regulatory Filings
2020-09-09 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report H1 2020
2020-08-21 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report H1 2020
2020-08-21 English
Amended number of shares and votes in Abliva AB (publ)
Share Issue/Capital Change
2020-07-31 English
Ändring av antal aktier och röster i Abliva AB (publ)
Share Issue/Capital Change
2020-07-31 Swedish
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements
2020-06-17 English
Abliva slutför den riktade emissionen om 20 MSEK till Hadean Ventures
Share Issue/Capital Change
2020-06-15 Swedish
Abliva completes the directed issue of MSEK 20 to Hadean Ventures
Capital/Financing Update
2020-06-15 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-06-01 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-05-29 English
Ändring av antal aktier och röster i Abliva AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2020-05-29 Swedish
Amended number of shares and votes in Abliva AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2020-05-29 English
Beslut vid årsstämma i NeuroVive Pharmaceutical AB (publ)
AGM Information
2020-05-20 Swedish
Resolutions from Annual General Meeting in NeuroVive Pharmaceutical AB (publ)
AGM Information
2020-05-20 English
Interim / Quarterly Report 2020
Interim / Quarterly Report Q1 2020
2020-05-20 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Q1 2020
2020-05-20 English
NeuroVive offentliggör utfall i företrädesemission
Share Issue/Capital Change
2020-05-05 Swedish
NeuroVive publishes outcome in rights issue
Share Issue/Capital Change
2020-05-05 English
NeuroVive’s Nomination Committee amends its proposal to the 2020 Annual General Meeting
AGM Information
2020-04-28 English
NeuroVives valberedning gör tillägg till sitt förslag inför årsstämman 2020
AGM Information
2020-04-28 Swedish
Offentliggörande av tilläggsprospekt avseende NeuoVives företrädesemission
Capital/Financing Update
2020-04-24 Swedish
Publication of supplementary prospectus related to NeuroVive’s rights issue
Capital/Financing Update
2020-04-24 English
Annual Report 2019
Annual Report FY 2019
2020-04-23 Swedish
Annual Report 2019
Annual Report FY 2019
2020-04-23 English
NeuroVive gör en riktad emission på 20 MSEK till Hadean Ventures, en ledande nordisk life science-investerare
Share Issue/Capital Change
2020-04-22 Swedish
NeuroVive makes a MSEK 20 directed share issue to leading Nordic life science investor Hadean Ventures
Share Issue/Capital Change
2020-04-22 English
Kallelse till årsstämma i NeuroVive Pharmaceutical AB (publ)
AGM Information
2020-04-20 Swedish
Notice of Annual General Meeting of NeuroVive Pharmaceutical AB (publ)
AGM Information
2020-04-20 English
NeuroVive offentliggör prospekt och ny finansiell information som återfinns i prospektet med anledning av förestående företrädesemission
Capital/Financing Update
2020-04-03 Swedish
NeuroVive publishes prospectus and new financial information included in the prospectus in connection with forthcoming rights issue
Capital/Financing Update
2020-04-03 English
NeuroVive Pharmaceutical AB (publ): kommuniké från extra bolagsstämma
Share Issue/Capital Change
2020-03-17 Swedish
NeuroVive Pharmaceutical AB (publ): report from EGM
AGM Information
2020-03-17 English
Interim / Quarterly Report 2019
Interim / Quarterly Report Q4 2019
2020-02-19 English
Earnings Release 2019
Earnings Release Q4 2019
2020-02-19 Swedish
Notice of Extraordinary General Meeting of NeuroVive Pharmaceutical AB (publ)
AGM Information
2020-02-19 English
Kallelse till extra bolagsstämma i NeuroVive Pharmaceutical AB (publ)
Proxy Solicitation & Information Statement
2020-02-19 Swedish
NeuroVive föreslår en företrädesemission om 74 MSEK samt accelererar den kliniska utvecklingen av KL1333
Capital/Financing Update
2020-02-19 Swedish
NeuroVive proposes a rights issue of MSEK 74 and accelerates the clinical development of KL1333
Capital/Financing Update
2020-02-19 English